What are the ways in which pharmaceutical companies and suppliers of ingredients, development and manufacturing services, and related technologies can take the customer-supplier relationship to the next level? DCAT Sharp Sourcing 2017, a one-day conference organized by the Drug, Chemical & Associated Technologies Association (DCAT), will answer that question by providing practical insights and best practices in pharmaceutical sourcing, procurement and supply management.
DCAT Sharp Sourcing 2017, which will be held on June 27, 2017, at the Hyatt Regency Hotel in New Brunswick, New Jersey, is designed for senior to mid-level executives engaged in the full spectrum of the pharmaceutical manufacturing value chain: raw materials to intermediates to active pharmaceutical ingredients (APIs) (small molecules and biologics) to formulation development to drug product manufacturing to packaging.
A Look Inside Sharp Sourcing 2017
Sharp Sourcing 2017 provides targeted information for sourcing, procurement and supply management professionals and executives from suppliers, contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs). The Buyers’ and Suppliers’ Forums, which run concurrently in the morning, are respectively targeted for buyers to provide peer insight in an interactive format and to suppliers to offer pharma customer-centric perspectives. The joint afternoon session brings together buyers and suppliers to share lessons learned, best practices and insights impacting the sponsor company-supplier relationship. Speakers for Sharp Sourcing 2017 include senior executives from Biogen, Bristol-Myers Squibb Company, Corbus Pharmaceuticals, Eli Lilly and Company, GE Healthcare, Johnson & Johnson, Lexicon Pharmaceuticals, Merck & Co. Inc., Pfizer and Siemens, among others.
Small-to-mid-sized pharmaceutical companies are an important customer base for suppliers, CMDOs and CMOs. So what is the outlook for this customer base and what are key topical issues impacting the customer-supplier relationship?
This year’s Suppliers’ Forum will answer those questions by featuring:
- A Wall Street view on financing and partnering activity of small-to-mid-sized pharma companies and the financial outlook for suppliers, CMOs, and CDMOs (RBC Capital Markets LLC)
- The latest regulatory requirements on starting materials (the regulatory consultancy, PharmaQ) and strategies for successfully defending regulatory starting materials, including the role of external manufacturing (Corbus Pharmaceuticals)
- Outsourcing strategies for APIs, including early-stage development, and ways to advance alliance management (Eli Lilly and Company and Lexicon Pharmaceuticals).
The Buyers’ Forum is an interactive session for sourcing, procurement and supply management executives that involve presentations, group discussion and knowledge sharing. This year’s program will feature three topics:
- Talent in sourcing and procurement with first-hand perspectives from Millennials and Generation Y professionals to provide insight on the unique skills these early-career professionals bring to the table, what senior executives can learn, and how their companies are developing their skills to meet future talent demands in sourcing and procurement (Bristol-Myers Squibb and Merck & Co. Inc.)
- Collaborative supply-chain planning will provide case examples and best practices in managing supplier relationships post-supplier mergers and acquisitions (Janssen Pharmaceuticals)
- Technology-led sourcing of CDMOs and CMOs will provide lessons learned for evaluating technology, capabilities, and scale when sourcing specialized capabilities from CDMOs and CMOs (Merck & Co. Inc.).
Joint Afternoon Session
Buyers and suppliers come together for the Joint Afternoon Session to learn from leading executives on practical ways to resolve common challenges in sourcing and procurement and on new tools for managing the customer-supplier relationship. This session will feature:
- A roundtable of chief procurement officers discussing specific challenges facing procurement organizations and their company initiatives to resolve those challenges by examining: ways to optimize operating models through global shared services, Big Data analytics in procurement, brand creation for the global procurement function, and supplier-enabled innovation (Johnson & Johnson, Pfizer, Biogen and GE Healthcare)
- A discussion of supply-chain financing, an emerging approach first adopted outside the pharmaceutical industry, which seeks to create a “win-win” solution for customers and suppliers in satisfying working capital requirements (Siemens and Pfizer)
- A market outlook for APIs with an in-depth analysis of supply and demand fundamentals and the factors influencing growth for small molecules and biologics for innovator and generic drugs in developed and emerging markets (Clarivate Analytics).
Networking and Keynote Speaker
DCAT is honored to have Phil Simms, Super Bowl XXI Most Valuable Player, former quarterback of the New York Giants as the keynote speaker for DCAT Sharp Sourcing 2017. Following his presentation on “Leading a Team,” a networking reception will occur.
Information about DCAT Sharp Sourcing, including how to register, may be found HERE.